REINVENT Registry (Registry of the Nerve Gap Repair From Integra)

NCT05339594 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 17

Last updated 2024-07-11

No results posted yet for this study

Summary

This is a prospective, multi-center, observational registry designed to evaluate two of Integra's collagen nerve gap repair products (NeuraGen® Nerve Guide and NeuraGen® 3D Nerve Guide Matrix). This registry will collect data on the outcome measures throughout the follow-up period for each patient. Data will be collected per standard of care.

Conditions

  • Peripheral Nerve Injuries

Interventions

DEVICE

NeuraGen

NeuraGen nerve guide is an absorbable implant for the repair of peripheral nerve gaps.

DEVICE

NeuraGen 3D

NeuraGen 3D Nerve guide matrix is a resorbable implant for the repair of peripheral nerve gaps.

Sponsors & Collaborators

  • Integra LifeSciences Corporation

    lead INDUSTRY

Principal Investigators

  • Maria Leonard, BSN,RN,CTBS · Integra LifeSciences

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-05-30
Primary Completion
2024-06-03
Completion
2024-06-03
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05339594 on ClinicalTrials.gov